At AliveX we generate & combine multi-omics data with computational biology and knowledge-empowered Model-Informed Drug Development (MIDD). Our AI immunology platform empowers a higher success rate of drug development at a lower cost and faster speed for immune-mediated diseases.
Headquarter Australia |
Countries of operation Australia |
Year founded 2019 (5 years) |
Funding status Private |
Company type SME |